Funder
National Institutes of Health
Cancer Prevention and Research Institute of Texas
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference49 articles.
1. Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM (2002) Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab 87(10):4522–4527
2. Albertsen PC, Walters S, Hanley JA (2000) A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol 163(2):519–523
3. Bipartisan Policy Center. Expanding access to obesity treatments for older adults. February 2022. Washington, D.C. 20005. https://bipartisanpolicy.org/download/?file=/wp-content/uploads/2022/02/BPC_ExpandingAccessToObesityFinal.pdf. Accessed 16 Sept 2022
4. Boyle P, Koechlin A, Bota M et al (2016) Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis. BJU Int 118(5):731–741
5. Brand JS, Rovers MM, Yeap BB et al (2014) Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PLoS One 9(7):e100409